Literature DB >> 2923502

Does rheumatoid factor protect lupus patients from the development of nephritis?

L Turner-Stokes1, M Jones, I Addison, M Mansell, D A Isenberg.   

Abstract

It has been suggested again recently that the presence of rheumatoid factor (RF) in the serum of patients with systemic lupus erythematosus (SLE) protects them from the development of nephritis. In this study the RF is measured by standard latex test and by radioimmunoassay to detect IgM, IgA, and IgG isotypes, in patients with SLE with (26 patients) and without (25 patients) renal involvement, and in a control group of 21 patients with idiopathic renal disease. In addition, patients with SLE and nephritis were tested during active and inactive phases of their disease. No significant protective effect was observed from the presence of RF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2923502      PMCID: PMC1003668          DOI: 10.1136/ard.48.1.14

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  4 in total

1.  Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy.

Authors:  G S Hill; N Hinglais; F Tron; J F Bach
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

2.  The clinical course of the proliferative and membranous forms of lupus nephritis.

Authors:  D S Baldwin; J Lowenstein; N F Rothfield; G Gallo; R T McCluskey
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

3.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

4.  Rheumatoid factor isotypes and renal disease in systemic lupus erythematosus.

Authors:  A Tarkowski; G Westberg
Journal:  Scand J Rheumatol       Date:  1987       Impact factor: 3.641

  4 in total
  3 in total

1.  Rheumatoid factor in patients with systemic lupus erythematosus.

Authors:  A Zoli; L Altomonte; R Caricchio; A Galossi; L Mirone; F Scuderi; M Magaro
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

Review 2.  Prognosis in systemic lupus erythematosus.

Authors:  J M Esdaile
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Autoantibodies to DNA topoisomerase II in juvenile rheumatoid arthritis.

Authors:  K L Zuklys; I S Szer; W Szer
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.